New tracheostomy tube holder aims to cut infections and boost comfort
NCT ID NCT07701226
First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time
Summary
This trial tests a new self-adhesive device for securing tracheostomy tubes in oral cancer patients. The device is designed to protect the skin, reduce wound infections, and make dressing changes quicker and less frequent. Researchers compare it to standard fixation methods in 150 patients to see if it improves safety, nursing efficiency, and patient comfort.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a novel self-adhesive bidirectional tracheostomy tube fixation device
- What this could lead to
- If effective, this device could reduce wound infections, skin damage, and discomfort for patients who need a tracheostomy tube, while also making care faster and easier for nurses.
- What could go wrong
- This is a single-center trial with 150 participants, so results may not apply to all patients. The device may not significantly improve outcomes compared to standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
150 people
The number who actually took part.
- Started
-
May 2025
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 18 years or older. * Patients with oral cancer who underwent tracheostomy or required a tracheostomy tube during hospitalization. * Patients who were conscious and had normal comprehension and communication ability. * Patients with intact cervical skin without skin damage, skin disease, or infection. * Patients who voluntarily agreed to participate and provided written informed consent. Exclusion Criteria: * Patients with pre-existing pressure injury, skin damage, allergy, or infection in the anterior cervical region before tracheostomy. * Pregnant women. * Minors under 18 years of age. * Patients with psychiatric disorders. * Patients who were unable to cooperate with the study procedures or outcome assessments as judged by the investigators.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Oral cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200011, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Incremental dead space versus capping trial to predict the Post-Decannulation respiratory status in tracheostomized critically ill patients: a physiological randomized crossover study
- Can a glowing light reveal hidden mouth lesions?
- Can a laser scan catch mouth cancer before it spreads?
- Can a prosthetic device restore quality of life after facial defects?
- Can a more intense radiation schedule outperform Chemo-Radiation for head and neck cancer?
- Can a glowing drug light up head and neck tumors?